Stockscreener 앱 받기
1.09
2.68%
-0.03
시간 외 거래:
1.09
전일 마감가:
$1.12
열려 있는:
$1.09
하루 거래량:
9,931
Relative Volume:
0.01
시가총액:
$11.23M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-10.66%
1개월 성능:
-14.17%
6개월 성능:
-41.08%
1년 성능:
-57.42%
1일 변동 폭
$1.065
$1.11
1주일 범위
$1.0601
$1.21
52주 변동 폭
$0.7701
$5.50
Gelteq Ltd Stock (GELS) Company Profile
GELS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
1.09 | 11.23M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Gelteq Ltd 주식(GELS)의 최신 뉴스
Is a relief rally coming for Gelteq Limited holdersOptions Play & Entry Point Confirmation Alerts - newser.com
Is Gelteq Limited stock supported by strong fundamentalsStop Loss & Verified Short-Term Trading Plans - newser.com
How moving averages guide Gelteq Limited tradingJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Will Gelteq Limited stock reach all time highs in 2025July 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
Key metrics from Gelteq Limited’s quarterly data2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound - MSN
Will Gelteq Limited stock continue dividend increases2025 Risk Factors & Low Risk High Reward Ideas - newser.com
How Does Wall Street Rate Shares Of Gelteq Ltd (GELS)? - fostersleader.com
What margin trends mean for Gelteq Limited stockWeekly Gains Report & Smart Swing Trading Techniques - newser.com
Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform - MSN
Will Gelteq Limited stock continue upward momentumTrade Entry Report & Low Risk Investment Opportunities - fcp.pa.gov.br
Is Gelteq Limited stock near bottom after decline2025 Analyst Calls & Weekly Top Gainers Alerts - newser.com
Market reaction to Gelteq Limited’s recent newsOil Prices & Real-Time Stock Entry Alerts - newser.com
What technical models suggest about Gelteq Limited’s comebackEarnings Trend Report & Real-Time Market Sentiment Alerts - newser.com
Real time pattern detection on Gelteq Limited stockTrade Risk Summary & Daily Technical Forecast Reports - newser.com
Is Gelteq Limited stock dividend yield sustainableWeekly Stock Summary & Capital Efficient Trading Techniques - newser.com
Gelteq (GELS) starts preclinical trial with Monash for oily, poorly soluble drugs - Stock Titan
Using portfolio simulators with Gelteq Limited includedWeekly Volume Report & Smart Money Movement Alerts - newser.com
Published on: 2025-10-21 21:31:20 - newser.com
Investment Review: How Gelteq Limited stock performs in interest rate cycles2025 Investor Takeaways & Community Shared Stock Ideas - Trung tâm Dự báo KTTV quốc gia
What analyst consensus says on Gelteq Limited stock2025 Retail Activity & Low Drawdown Momentum Ideas - Trung tâm Dự báo KTTV quốc gia
Is Gelteq Limited stock a buy on dips2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - Trung tâm Dự báo KTTV quốc gia
How Gelteq Limited stock performs in interest rate cyclesLong Setup & AI Powered Market Entry Strategies - Trung tâm Dự báo KTTV quốc gia
Published on: 2025-10-18 12:21:43 - Trung tâm Dự báo KTTV quốc gia
Can Gelteq Limited stock sustain institutional interest2025 Historical Comparison & Expert Curated Trade Setups - Trung tâm Dự báo KTTV quốc gia
Is Gelteq Limited stock ready for a breakout2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Gelteq Limited (GELS) Stock Price, News, Quote & History - Yahoo
Gelteq Limited (GELS) Latest Press Releases & Corporate News - Yahoo
Gelteq partners with Melbourne Health to develop bowel cancer prevention gel - Investing.com India
HAMSB product development: Gelteq and Melbourne Health partner to target bowel polyp growth reduction - Stock Titan
Gelteq Ltd (GELS) 재무 분석
Gelteq Ltd (GELS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.60%
0.45%
자본화:
|
볼륨(24시간):